Skip to main content

News & Events

Meetings, Workshops & Trainings
Regional Health Information Exchanges as Critical National Infrastructure: Supporting Federal Agency Missions
September 25, 2024
Learn More
View All Events
Meetings, Workshops & Trainings
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods
September 10, 2024
Learn More
View All Events
Meetings, Workshops & Trainings
2025 ISPE Annual Meeting
August 22, 2025
Learn More
View All Events
FDA Safety Communications
FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications
Learn More
View All Alerts
FDA Advisory Committee Meetings
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and Psychopharmacologic Drugs Advisory Committee Meeting
Learn More
View All Meetings

Latest Publications & Presentations

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative
Publication
03/24/2026

The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review…

Association of GLP-1 Receptor Agonists with Intentional Self-Harm in Patients with Type 2 Diabetes: A Sentinel Distributed Database Study
Publication
03/18/2026

The U.S. Food and Drug Administration (FDA) investigated the potential risk of suicidal ideation and behaviors for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) on learning of post-…

View All

Recent Sentinel Activity

View All Recent Activity